Literature DB >> 15722453

Ligand-binding regulation of LXR/RXR and LXR/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation.

Liduo Yue1, Fei Ye, Chunshan Gui, Haibin Luo, Jianhua Cai, Jianhua Shen, Kaixian Chen, Xu Shen, Hualiang Jiang.   

Abstract

Liver X receptor (LXR) and peroxisome proliferator-activated receptor (PPAR) are two members of nuclear receptors involved in the nutrient metabolisms of dietary fatty acid and cholesterol. They are found to be of cross-talk function in that LXR regulates fatty acid synthesis and PPAR controls fatty acid degradation. LXRs (LXRalpha and LXRbeta) function by forming obligate heterodimers with the retinoid X receptor (RXR), and subsequently binding to specific DNA response elements within the regulatory regions of their target genes. In this work, the kinetic features concerning LXR/RXR and LXR/PPAR interactions have been fully investigated using surface plasmon resonance (SPR) technology. It is found that LXRs could bind to all the three PPAR subtypes, PPARalpha, PPARgamma and PPARdelta with different binding affinities, and such receptor/receptor interactions could be regulated by ligand binding. Moreover, molecular dynamics (MD) simulations were performed on six typical complex models. The results revealed that ligands may increase the interaction energies between the receptor interfaces of the simulated receptor/receptor complexes. The MD results are in agreement with the SPR data. Further analyses on the MD results indicated that the ligand binding might increase the hydrogen bonds between the interfaces of the receptor/receptor complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722453      PMCID: PMC2279270          DOI: 10.1110/ps.04951405

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  36 in total

Review 1.  The PPARs: from orphan receptors to drug discovery.

Authors:  T M Willson; P J Brown; D D Sternbach; B R Henke
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

2.  Biosensor analysis of drug-target interactions: direct and competitive binding assays for investigation of interactions between thrombin and thrombin inhibitors.

Authors:  R Karlsson; M Kullman-Magnusson; M D Hämäläinen; A Remaeus; K Andersson; P Borg; E Gyzander; J Deinum
Journal:  Anal Biochem       Date:  2000-02-01       Impact factor: 3.365

3.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

4.  Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors.

Authors: 
Journal:  Curr Opin Biotechnol       Date:  1997-02-01       Impact factor: 9.740

Review 5.  Ubiquitous receptor: structures, immunocytochemical localization, and modulation of gene activation by receptors for retinoic acids and thyroid hormones.

Authors:  C Song; R A Hiipakka; J M Kokontis; S Liao
Journal:  Ann N Y Acad Sci       Date:  1995-06-12       Impact factor: 5.691

6.  A canonical structure for the ligand-binding domain of nuclear receptors.

Authors:  J M Wurtz; W Bourguet; J P Renaud; V Vivat; P Chambon; D Moras; H Gronemeyer
Journal:  Nat Struct Biol       Date:  1996-01

7.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.

Authors:  Yong-Xu Wang; Chih-Hao Lee; Sambath Tiep; Ruth T Yu; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

8.  Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.

Authors:  R T Gampe; V G Montana; M H Lambert; A B Miller; R K Bledsoe; M V Milburn; S A Kliewer; T M Willson; H E Xu
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

9.  Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators.

Authors:  Y Kodera; K Takeyama; A Murayama; M Suzawa; Y Masuhiro; S Kato
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

10.  Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.

Authors:  Tomohiro Ide; Hitoshi Shimano; Tomohiro Yoshikawa; Naoya Yahagi; Michiyo Amemiya-Kudo; Takashi Matsuzaka; Masanori Nakakuki; Shigeru Yatoh; Yoko Iizuka; Sachiko Tomita; Ken Ohashi; Akimitsu Takahashi; Hirohito Sone; Takanari Gotoda; Jun-ichi Osuga; Shun Ishibashi; Nobuhiro Yamada
Journal:  Mol Endocrinol       Date:  2003-05-01
View more
  25 in total

1.  Dynamical probing of allosteric control in nuclear receptors.

Authors:  Mark A Cunningham
Journal:  J Mol Model       Date:  2012-01-06       Impact factor: 1.810

Review 2.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

3.  Phase 0 of the Xenobiotic Response: Nuclear Receptors and Other Transcription Factors as a First Step in Protection from Xenobiotics.

Authors:  William S Baldwin
Journal:  Nucl Receptor Res       Date:  2019-11-20

4.  The Arabidopsis CORONATINE INSENSITIVE1 protein is a jasmonate receptor.

Authors:  Jianbin Yan; Chi Zhang; Min Gu; Zhiyan Bai; Weiguo Zhang; Tiancong Qi; Zhiwei Cheng; Wen Peng; Haibin Luo; Fajun Nan; Zhao Wang; Daoxin Xie
Journal:  Plant Cell       Date:  2009-08-28       Impact factor: 11.277

Review 5.  Biochemical and physiological function of stearoyl-CoA desaturase.

Authors:  Chad M Paton; James M Ntambi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-09       Impact factor: 4.310

Review 6.  PPARs and the cardiovascular system.

Authors:  Milton Hamblin; Lin Chang; Yanbo Fan; Jifeng Zhang; Y Eugene Chen
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

7.  MUTATIONS IN LIVER X RECEPTOR ALPHA THAT IMPAIR DIMERIZATION AND LIGAND DEPENDENT TRANSACTIVATION.

Authors:  Shimpi Bedi; Heather A Hostetler; Stanley Dean Rider
Journal:  Nucl Receptor Res       Date:  2017

8.  LXR as a novel antithrombotic target.

Authors:  Michael Spyridon; Leonardo A Moraes; Chris I Jones; Tanya Sage; Parvathy Sasikumar; Giovanna Bucci; Jonathan M Gibbins
Journal:  Blood       Date:  2011-03-16       Impact factor: 22.113

9.  Systems analysis of small signaling modules relevant to eight human diseases.

Authors:  Kelly F Benedict; Feilim Mac Gabhann; Robert K Amanfu; Arvind K Chavali; Erwin P Gianchandani; Lydia S Glaw; Matthew A Oberhardt; Bryan C Thorne; Jason H Yang; Jason A Papin; Shayn M Peirce; Jeffrey J Saucerman; Thomas C Skalak
Journal:  Ann Biomed Eng       Date:  2010-12-04       Impact factor: 3.934

10.  Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.

Authors:  Mingming Gao; Le Bu; Yongjie Ma; Dexi Liu
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.